165 related articles for article (PubMed ID: 36900270)
1. Tumor Microenvironment and Immune Response in Lip Cancer.
Gkegka AG; Koukourakis MI; Lambropoulou M; Giatromanolaki A
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900270
[TBL] [Abstract][Full Text] [Related]
2. Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer.
Gkegka AG; Koukourakis MI; Katotomichelakis M; Giatromanolaki A
Head Neck Pathol; 2023 Jun; 17(2):422-432. PubMed ID: 36586079
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
[TBL] [Abstract][Full Text] [Related]
4. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
5. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
Chung YR; Kim HJ; Jang MH; Park SY
Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Infiltrating CD20
Suárez-Sánchez FJ; Lequerica-Fernández P; Rodrigo JP; Hermida-Prado F; Suárez-Canto J; Rodríguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494389
[TBL] [Abstract][Full Text] [Related]
8. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
11. Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma.
Turner CP; McLay J; Hermans IF; Correia J; Bok A; Mehrabi N; Gock S; Highet B; Curtis MA; Dragunow M
Pathology; 2022 Jun; 54(4):417-424. PubMed ID: 35082053
[TBL] [Abstract][Full Text] [Related]
12. FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.
Giatromanolaki A; Banham AH; Harris AL; Koukourakis MI
Exp Lung Res; 2019; 45(3-4):76-83. PubMed ID: 31134811
[No Abstract] [Full Text] [Related]
13. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E
Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602
[TBL] [Abstract][Full Text] [Related]
15. Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer.
Ahn S; Chung YR; Seo AN; Kim M; Woo JW; Park SY
PLoS One; 2020; 15(5):e0233037. PubMed ID: 32401825
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
BMC Cancer; 2021 Mar; 21(1):286. PubMed ID: 33726701
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
20. Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability.
Giatromanolaki A; Kouroupi M; Kontomanolis EN; Koukourakis MI
Immunobiology; 2021 May; 226(3):152078. PubMed ID: 33725493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]